Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T01:18:20.836Z Has data issue: false hasContentIssue false
  • English
  • Français

Undetected Vancomycin-Resistant Enterococcus in Surgical Intensive Care Unit Patients

Published online by Cambridge University Press:  02 January 2015

Richard A. Zuckerman ,
Lynn Steele ,
Richard A. Venezia  and
Ellis H. Tobin
Richard A. Zuckerman
Affiliation:
Albany Medical Center, Albany Medical College, Albany, New York
Lynn Steele
Affiliation:
Albany Medical Center, Albany Medical College, Albany, New York
Richard A. Venezia
Affiliation:
Albany Medical Center, Albany Medical College, Albany, New York
Ellis H. Tobin*
Affiliation:
Albany Medical Center, Albany Medical College, Albany, New York
*
Division of Infectious Diseases, Albany Medical College, 47 New Scotland Ave, Albany, NY 12208
Get access Rights & Permissions [Opens in a new window]

Abstract

The rates of vancomycin-resistant Enterococcus (VRE) in a high-risk population were investigated prospectively using an active surveillance method. The costs of conducting active surveillance were calculated. Among the 10 patients found to have VRE, routine cultures identified 3 (30%); thus, 70% of the VRE-colonized patients would have gone undetected in the absence of active surveillance. The total cost for 5 weeks of active surveillance was $2,234. Although active surveillance identified a high rate of VRE-colonized patients who otherwise may not have been identified, it remains to be determined if the additional costs are justified and result in reduced transmission.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 10 , October 1999 , pp. 685 - 686
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16:105–113.CrossRefGoogle Scholar
2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M2-A5. Villanova, PA: National Committee for Clinical Laboratory Standards; 1994.Google Scholar
3. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
4. Wells, CL, Juni, BA, Cameron, SB, Mason, KR, Dunn, DL, Ferren, P, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and surgical patients. Clin Infect Dis 1995;21:45–50.CrossRefGoogle ScholarPubMed
5. Slaughter, S, Hayden, MK, Nathan, C, Hu, TC, Rice, T, Van Voohis, J, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448–456.CrossRefGoogle Scholar
6. Montecalvo, MA, de Lencastre, H, Carraher, M, Gedris, C, Chung, M, Van Horn, K, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium . Infect Control Hosp Epidemiol 1995;16:680–685.CrossRefGoogle ScholarPubMed